"Biotechnology is a time of new risks and opportunities."
That's the takeaway from a new report from the Johns Hopkins Bloomberg School of Public Health, which notes that while "the benefits of biotechnology are tangible and obvious to the world," there are also "risks to biotechnological progress"including the possibility that a product "escapes from containment, causing harm to people, animals, or the environment."
The report, titled "Biotechnology Governance in a Time of New Risks and Opportunities," notes that "accidents are also possible if some biotechnology product 'escapes' from containment, causing harm to people, animals, or the environment."
That's especially true now that "synthetic biology tools like CRISPR, which allows for precise gene editing and gene-expression technologies, biotechnology is a more powerful and accessible technology than ever before."
In fact, the report notes, "nations have evolved their own systems to govern laboratories and biotechnologies, and there is no one place at the international level that harmonizes those different approaches."
That's especially true when it comes to genetically modified organisms (GMOs), which have their own regulatory systems around the world.
"Still, it remains important to examine how responsible governance could be achieved and to advance the development of Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.
Here are the star companies that have succeeded in their corporate social responsibility (CSR) programs. The companies were gathered by Civic 50, a national initiative to survey and rank S&P 500 corporations on how they engage with the communities they serve and utilize best practices in their corporate cultures.